<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02301052</url>
  </required_header>
  <id_info>
    <org_study_id>CT-9377-7127</org_study_id>
    <nct_id>NCT02301052</nct_id>
  </id_info>
  <brief_title>Evaluation of Allium Ampeloprasum Spp.Iranicum Cream Effect for the Management of Hemorrhoids Symptoms</brief_title>
  <official_title>Double Blind Randomized Placebo-control Trial of Allium Ampeloprasum Spp.Iranicum Cream Effect for the Management of Hemorrhoids Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shiraz University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shiraz University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose of study is evaluation of Allium ampeloprasum Spp.Iranicum cream efficacy in
      management of symptomatic hemorrhoids in a double blind randomized placebo-control trial
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose of study: evaluation of Allium ampeloprasum Spp.Iranicum cream efficacy for the
      management of hemorrhoids study design:Double blind randomized placebo-control trial,
      uni-central Study population: Participants having symptomatic hemorrhoids attending Shiraz
      University of Medical Sciences clinics Inclusion criteria: Patients with symptomatic
      hemorrhoids(GRADE 1-4) without need to emergency operation according to physical examination
      Exclusion criteria: Participants having anal fissure or inflammatory bowel disease or history
      of gastrointestinal cancer Sample size: 75 patients (tree groups) Interventions: Topical
      Allium ampeloprasum cream/ placebo cream/anti-hemorrhoid cream Time period: 3 week Outcome
      measures: pain,itching, bleeding, defecate discomfort, total improvement, constipation
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain (visual analogue scale(0-10))</measure>
    <time_frame>3 weeks</time_frame>
    <description>method of measurement: visual analogue scale(0-10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>bleeding ( questionnaire)</measure>
    <time_frame>3 weeks</time_frame>
    <description>method of measurement questionnaire:grade (0-4) that was defined as follow: 0=no symptom, 1= mild, 2=moderate, 3= severe, 4=very severe.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>itching ( questionnaire)</measure>
    <time_frame>3 weeks</time_frame>
    <description>method of measurement questionnaire: grade (0-4) that was defined as follow: 0=no symptom, 1= mild, 2=moderate, 3= severe, 4=very severe.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>defecate discomfort (visual analogue scale(0-10)</measure>
    <time_frame>3 weeks</time_frame>
    <description>method of measurement: visual analogue scale(0-10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>total improvement (visual analogue scale(0-10)</measure>
    <time_frame>3 weeks</time_frame>
    <description>method of measurement:visual analogue scale(0-10)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>constipation (questionnaire)</measure>
    <time_frame>3 weeks</time_frame>
    <description>method of measurement: questionnaire</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Hemorrhoids</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo topical cream 2 cc twice daily for 3 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anti-hemorrhoid topical cream drug</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Anti hemorrhoid topical cream as a standard drug 2 cc twice daily for 3 week</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Leek topical cream</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Leek (Allium Ampeloprasum Spp.Iranicum) topical cream 2 cc twice daily for 3 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Leek topical cream</intervention_name>
    <description>Leek (Allium Ampeloprasum Spp.Iranicum) topical cream 2 cc twice daily for 3 weeks</description>
    <arm_group_label>Leek topical cream</arm_group_label>
    <other_name>Allium Ampeloprasum Spp.Iranicum topical cream</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo topical cream</intervention_name>
    <description>placebo topical cream 2 cc twice daily for 3 weeks</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anti-hemorrhoid topical cream</intervention_name>
    <description>Anti hemorrhoid topical cream 2 cc twice daily for 3 weeks(This cream consists of lidocaine (5% w/w), hydrocortisone acetate (7.5% w/w), aluminium sub-acetate (3.5% w/w), and zinc oxide (18% w/w). 30 g )</description>
    <arm_group_label>Anti-hemorrhoid topical cream drug</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Participants having symptomatic hemorrhoids(GRADE 1-4) without need to emergency
             operation according to physical examination

          -  Participants who do not use drugs other than the study drug and the control drug to
             treat their hemorrhoids during the study period:

        Exclusion Criteria:

          -  Participants having anal fissure or inflammatory bowel disease or history of
             gastrointestinal cancer

          -  Participants having hypersensitive predisposition or hypersensitive to Allium
             ampeloprasum or history of skin hypersensivity

          -  Female participants under pregnancy or during breastfeeding period

          -  Participants complicated by serious cardio cerebro vascular diseases, hepatic and
             renal diseases, diseases of hemopoietic system or neurologic disorders or ascitis g-
             history of steroid or anticoagulant drug consumption
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leyla Ghahramani, Assistant proffessor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shiraz University of Medical Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seyed Hamdollah Mosavat, MD</last_name>
    <phone>00987132351087</phone>
    <email>hamdi_88114@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Vice-Chancellery of Research and Technology office, Shiraz University of Medical Sciences</name>
      <address>
        <city>Shiraz</city>
        <state>Fars</state>
        <zip>009871</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seyed Hamdollah Mosavat, MD</last_name>
      <email>hamdi_88114@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2014</study_first_submitted>
  <study_first_submitted_qc>November 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2014</study_first_posted>
  <last_update_submitted>November 24, 2014</last_update_submitted>
  <last_update_submitted_qc>November 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shiraz University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Leyla Ghahramani</investigator_full_name>
    <investigator_title>Shiraz university of medical sciences</investigator_title>
  </responsible_party>
  <keyword>hemorrhoids</keyword>
  <keyword>Allium Ampeloprasum</keyword>
  <keyword>herbal medicine</keyword>
  <keyword>traditional persian medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

